Jianmin Fu

发表

Methyl-containing pharmaceuticals: Methylation in drug design.

Shaoyi Sun, Jianmin Fu, 2018, Bioorganic & medicinal chemistry letters.

Tetracyclic spirooxindole blockers of hNaV1.7: activity in vitro and in CFA-induced inflammatory pain model

Tom H. H. Hsieh, Shaoyi Sun, Jianmin Fu, 2013, Medicinal Chemistry Research.

Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors.

Y. P. Goldberg, Nagasree Chakka, Jianmin Fu, 2012, Bioorganic & medicinal chemistry letters.

Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain.

Jianmin Fu, W. Young, Shifeng Liu, 2011, Bioorganic & medicinal chemistry letters.

Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.

D. McLaren, N. Dales, N. Pokrovskaia, 2015, Bioorganic & medicinal chemistry.

Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects.

D. McLaren, B. Hubbard, N. Dales, 2014, Bioorganic & medicinal chemistry letters.

Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.

D. McLaren, Nagasree Chakka, Shaoyi Sun, 2013, Journal of medicinal chemistry.

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer.

Andrew M Haidle, Matthew L. Maddess, J. Cumming, 2022, Journal of medicinal chemistry.

Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases.

D. McLaren, B. Hubbard, N. Dales, 2014, Bioorganic & medicinal chemistry letters.

Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.

Andrea Lindgren, L. Lin, Shaoyi Sun, 2013, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1).

Y. P. Goldberg, Jianmin Fu, M. Mattice, 2012, Bioorganic & medicinal chemistry letters.

Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain.

Jianmin Fu, W. Young, Shifeng Liu, 2011, Bioorganic & medicinal chemistry letters.

Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.

D. McLaren, N. Dales, N. Pokrovskaia, 2015, Bioorganic & medicinal chemistry.

Tetracyclic spirooxindole blockers of hNaV1.7: activity in vitro and in CFA-induced inflammatory pain model

Tom H. H. Hsieh, Shaoyi Sun, Jianmin Fu, 2013, Medicinal Chemistry Research.